Crystal structure of Torpedo Californica acetylcholinesterase in complex with 2-{1-[2-(6-Chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-1H-1,2,3-triazol-4-yl}-N-[4-(hydroxy)-3-methoxybenzyl]acetamide
Coordinates
PDB Format
Method
X-RAY DIFFRACTION
1.90 Å
Oligo State
homo-dimer
Ligands
6 x
NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.1:
3
residues within 4Å:
Chain A:
N.59,
S.61,
T.62
1 PLIP interactions:
1 interactions with chain A
Hydrogen bonds:
A:S.61
NAG.2:
1
residues within 4Å:
Chain A:
N.416
3 PLIP interactions:
3 interactions with chain A
Hydrogen bonds:
A:N.416
Water bridges:
A:N.416,
A:N.416
NAG.3:
2
residues within 4Å:
Chain A:
E.455,
N.457
2 PLIP interactions:
2 interactions with chain A
Hydrogen bonds:
A:E.455,
A:N.457
NAG.8:
3
residues within 4Å:
Chain B:
N.59,
S.61,
T.62
1 PLIP interactions:
1 interactions with chain B
Hydrogen bonds:
B:S.61
NAG.9:
1
residues within 4Å:
Chain B:
N.416
2 PLIP interactions:
2 interactions with chain B
Hydrogen bonds:
B:N.416
Water bridges:
B:N.416
NAG.10:
1
residues within 4Å:
Chain B:
N.457
2 PLIP interactions:
2 interactions with chain B
Hydrogen bonds:
B:E.455,
B:N.457
2 x
E0Z:
2-[1-[2-[(3-chloranylacridin-9-yl)amino]ethyl]-1,2,3-triazol-4-yl]-~{N}-[(3-methoxy-4-oxidanyl-phenyl)methyl]ethanamide(Non-covalent)
Galdeano, C. et al., Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules (2018)
